Clinical Research Directory
Browse clinical research sites, groups, and studies.
Impact of Advanced Parkinson Therapies on Clinical Status: Deep Brain Stimulation and Foslevodopa/Foscarbidopa
Sponsor: Medical University of Warsaw
Summary
The goal of this observational study is to learn how treatment with selected advanced therapies for Parkinson's disease affect disease motor symptoms, cognition, body weight, body composition and inflammatory biomarkers in people with advanced Parkinson's disease. The main questions it aims to answer are: * How do clinical symptoms, cognitive function, body composition and blood biomarkers change during the first 12 months after starting the treatment? * Are there differences in outcomes between participants treated with DBS and those treated with foslevodopa/foscarbidopa infusion? Participants will: * Undergo deep brain stimulation (DBS) or start continuous subcutaneous foslevodopa/foscarbidopa infusion as part of their routine clinical care. * Attend study visits over 12 months and complete assessments of motor and non-motor symptoms, cognition, gait and balance. * Provide blood samples and undergo magnetic resonance imaging (MRI) and body composition measurements.
Official title: The Impact of Selected Advanced Therapies on the Clinical Status of Patients With Parkinson's Disease.
Key Details
Gender
All
Age Range
40 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
92
Start Date
2025-03-19
Completion Date
2029-03-28
Last Updated
2026-11-18
Healthy Volunteers
No
Locations (1)
Department of Neurology at Mazowiecki Bródnowski Hospital
Warsaw, Masovian Voivodeship, Poland